These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22924938)

  • 1. Novel antiviral therapeutics to control foot-and-mouth disease.
    Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
    J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.
    Diaz-San Segundo F; Dias CC; Moraes MP; Weiss M; Perez-Martin E; Salazar AM; Grubman MJ; de Los Santos T
    Virology; 2014 Nov; 468-470():283-292. PubMed ID: 25216089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
    Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ
    J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.
    Ramírez-Carvajal L; Díaz-San Segundo F; Hickman D; Long CR; Zhu J; Rodríguez LL; de los Santos T
    J Virol; 2014 Oct; 88(19):11140-53. PubMed ID: 25031341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus.
    Dias CC; Moraes MP; Segundo FD; de los Santos T; Grubman MJ
    J Interferon Cytokine Res; 2011 Feb; 31(2):227-36. PubMed ID: 20874428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
    Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
    J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
    Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
    J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
    Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM
    Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
    Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
    J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus.
    Kim SM; Kim SK; Park JH; Lee KN; Ko YJ; Lee HS; Seo MG; Shin YK; Kim B
    Antiviral Res; 2014 Apr; 104():52-8. PubMed ID: 24485895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
    Moraes MP; Chinsangaram J; Brum MC; Grubman MJ
    Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC.
    Wong JP; Yang H; Nagata L; Kende M; Levy H; Schnell G; Blasetti K
    Vaccine; 1999 Mar; 17(13-14):1788-95. PubMed ID: 10194841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
    de Avila Botton S; Brum MC; Bautista E; Koster M; Weiblen R; Golde WT; Grubman MJ
    Vaccine; 2006 Apr; 24(17):3446-56. PubMed ID: 16522345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.
    Diaz-San Segundo F; Moraes MP; de Los Santos T; Dias CC; Grubman MJ
    J Virol; 2010 Feb; 84(4):2063-77. PubMed ID: 19955313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans.
    Caskey M; Lefebvre F; Filali-Mouhim A; Cameron MJ; Goulet JP; Haddad EK; Breton G; Trumpfheller C; Pollak S; Shimeliovich I; Duque-Alarcon A; Pan L; Nelkenbaum A; Salazar AM; Schlesinger SJ; Steinman RM; Sékaly RP
    J Exp Med; 2011 Nov; 208(12):2357-66. PubMed ID: 22065672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.
    Diaz-San Segundo F; Dias CC; Moraes MP; Weiss M; Perez-Martin E; Owens G; Custer M; Kamrud K; de los Santos T; Grubman MJ
    J Virol; 2013 May; 87(10):5447-60. PubMed ID: 23468490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.